Fulcrum Therapeutics, Inc.

Q2 2026 13F Holders

Symbol: FULC
CUSIP: 359616109
Type: Equity
Class: COM
Num filings: 165
Total reported value, excl. options: $315 M

Compare 2026 Q2 to

Manager	Report Date	Value ($000)	Shares	Option Type